PRVA

Privia Health Group, Inc. Health Care Services-Health Services Russell 3000
$21.48Close $2.7BMarket cap $19.10 – $28.1052-week range Nov 5, 2026Next report · before the open

Highlights

Strengths

  • Volume drying up last 10 days 29% under the 50-day average
  • Earnings growing EPS +228% year on year, faster than the quarter before (+257 pts)

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Lagging the market RS 25 · weaker than 75% of stocks over 12 months
  • Results soon Nov 5, 2026, in 4 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 24%
1wk down 4.1% price change
1mo up 9.1% price change
12-month return down 12% market up 11% · its own down 27%
F-score — — Not assessed
Altman Z″ 2.77 Low risk
P/E 115.8× price / earnings
PEG 2.10 P/E / EPS growth
P/B 3.6× price / book
Earnings yield up 1.6% EBIT / enterprise value
Cheaper than 51% of the market · around average
Revenue growth up 22% year on year
EPS growth up 228% latest quarter · +257 pts
Sales growth up 21% latest quarter · -4 pts
ROE up 3% return on equity
Free cash margin up 8% $163.4M FCF
D/E — long-term debt / equity
Net debt / EBITDA -10.9× net cash
Interest cover —EBIT / interest

Trade setup

ATR% 2.9% $0.61 a day · 2×ATR $20.26
RS 25 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 0.7× vs 50-day average
Up/down volume 1.07 50 sessions
Implied move — no option chain · report Nov 5, 2026
Contractions 3 32% → 12% → 8%
Pivot $23.13 7.1% below
Volume dry-up 0.7× 10 vs 50 sessions
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: fails
  • 50-day average above the 150 and 200-day: fails
  • Price above the 50-day average: passes
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 2.7% over the year, from 120m to 124m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Aug 6, 2026
Results reaction Aug 6, 2026-7% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.1B +22% on FY2024
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $817.1M FY2021 · $966.2M FY2022 · $1.4B FY2023 · $1.7B FY2024 · $1.7B FY2025 · $2.1B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $22.9M +59% on FY2024
-$200M $0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $31.2M FY2021 · -$188.2M FY2022 · -$8.6M FY2023 · $23.1M FY2024 · $14.4M FY2025 · $22.9M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $163.4M +50% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $38.5M FY2021 · $54.5M FY2022 · $47.1M FY2023 · $80.7M FY2024 · $109.3M FY2025 · $163.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 1%
  • Free cash 8%
-20% 0% 10% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 4% · Free cash 5% FY2021 · Net -19% · Free cash 6% FY2022 · Net -1% · Free cash 3% FY2023 · Net 1% · Free cash 5% FY2024 · Net 1% · Free cash 6% FY2025 · Net 1% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $84.6M · Long-term debt $32.8M FY2021 · Cash $320.6M · Long-term debt $33.2M FY2022 · Cash $348.0M · Long-term debt $0 FY2023 · Cash $389.5M FY2024 · Cash $491.1M FY2025 · Cash $479.7M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 123.60m +28.8% since FY2020
123.60m 95.99m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 95.99m FY2021 · 107.84m FY2022 · 114.69m FY2023 · 118.22m FY2024 · 120.31m FY2025 · 123.60m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $817.1M $966.2M $1.4B $1.7B $1.7B $2.1B
Operating income $25.4M -$217.4M -$19.1M $20.6M $17.0M $34.2M
Net income $31.2M -$188.2M -$8.6M $23.1M $14.4M $22.9M
Net margin 4% -19% -1% 1% 1% 1%
Earnings per share $0.33 -$1.83 -$0.08 $0.19 $0.11 $0.18
Free cash flow $38.5M $54.5M $47.1M $80.7M $109.3M $163.4M
Free cash margin 5% 6% 3% 5% 6% 8%
Cash $84.6M $320.6M $348.0M $389.5M $491.1M $479.7M
Long-term debt $32.8M $33.2M $0 — — —
Shareholders' equity $146.7M $426.9M $499.1M $561.4M $635.2M $737.2M
Shares outstanding 95.99m 107.84m 114.69m 118.22m 120.31m 123.60m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 7, 2024 Quarterly ↗ Sep 30, 2024 38d
Aug 8, 2024 Quarterly ↗ Jun 30, 2024 39d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Feb 27, 2024 Annual ↗ Dec 31, 2023 58d
Nov 3, 2023 Quarterly ↗ Sep 30, 2023 34d

Current reports

FiledDisclosed
Aug 18, 2026 Director or officer change ↗
Aug 6, 2026 Results ↗
Jul 7, 2026 Director or officer change ↗
May 22, 2026 Shareholder vote ↗
May 7, 2026 Results ↗
Feb 26, 2026 Results ↗
Dec 8, 2025 Other events ↗
Nov 6, 2025 Results ↗
Oct 28, 2025 Other events ↗
Sep 23, 2025 Other events ↗
Aug 29, 2025 Regulation FD ↗
Aug 7, 2025 Results ↗